Treosulfan Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: 1,2,3, 4-Butanetetrol, 1,4-dimethanesulfonate, [R-(R*,S*)]-, Dihydroxybusulfan, Grafapex, Ovastat, Treo +2 more

Pipeline

Phase 1: 1Phase 2: 2Phase 2/3: 1

Top Sponsors

medac GmbH1
St. Anna Kinderkrebsforschung1
Insel Gruppe AG, University Hospital Bern1
Fred Hutchinson Cancer Center1

Indications

Cancer4
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)1
Adult Diffuse Large Cell Lymphoma1
Refractory Marginal Zone Lymphoma1
Refractory Small Lymphocytic Lymphoma1

Other2 trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Phase 2/3

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

Phase 2

Chicago, Illinois1 trial

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

University of Illinois

Phase 1

Seattle, Washington1 trial

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.